Skip to search formSkip to main contentSkip to account menu

MPL NP_005364.1:p.W515L

Known as: MPL p.Trp515Leu, MPL NP_005364.1:p.Trp515Leu, TPO-R W515L 
A change in the amino acid residue at position 515 in the thrombopoietin receptor protein where tryptophan has been replaced by leucine.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Acute megakaryoblastic leukemia (AMKL) is a rare type of leukemia characterized by indefinite proliferation of megakaryocytes… 
2016
2016
The thrombopoietin receptor (MPL) has been shown to be mutated (MPL W515L) in myelofibrosis and thrombocytosis yet new approaches… 
2012
2012
The Rockefeller University Press $30.00 J. Exp. Med. Vol. 209 No. 2 259-273 www.jem.org/cgi/doi/10.1084/jem.20111694 259 Janus… 
2010
2010
Somatic activating mutations in MPL, the thrombopoietin receptor, occur in the myeloproliferative neoplasms, although virtually… 
2010
2010
JAK2 V617F and MPL W515L/K mutations have been reported in approximately 50% and 5% of the patients with essential… 
2009
2009
Acquired mutations in the juxtamembrane region of MPL (W515L or W515K), the receptor for thrombopoietin, have been reported in… 
2009
2009
To the Editor: A number of somatic mutations have been identified in myeloproliferative neoplasms (MPN) in the past few years… 
2008
2008
As JAK2 V617F, MPL W515L is a novel acquired mutation that induces constitutive cytokine-independent activation of the JAK-STAT… 
2006
2006
Auto-antibodies (aAbs) to thyroid peroxidase (TPO) interact with a restricted immunodominant region (IDR) divided into two… 
1998
1998
Thrombopoietin (TPO) is a megakaryocyte growth and differentiation factor. It consists of a characteristic two domain structure…